Life Sciences
Top stories summarized by our editors
4/20/2018

Bill Gates said at the Malaria Forum conference in London that biotech mosquitoes are critical in the fight against malaria and that exploring gene-editing technologies such as CRISPR should not be jeopardized despite the controversy surrounding it. Bill added that such technologies will not wipe out the mosquitoes that carry malaria, but provide an opportunity to help limit the reservoir of disease and stop disease transmission among people.

Full Story:
New York Post
More Summaries:
Bill Gates, Malaria, Crispr
4/20/2018

The Environmental Protection Agency has been urged by a group of bipartisan senators to halt issuance of hardship waivers to oil refiners, which exempt the refiners from mixing biofuels into gasoline. In recent months, the agency has reportedly issued 25 hardship waivers to refineries, including those operated by energy giants ExxonMobil, Chevron and Andeavor, and the lawmakers wanted the EPA to justify the unusual number of large, profitable refiners avoiding the biofuel blending obligations.

Full Story:
CNBC
4/20/2018

Eli Lilly and Co. kicked off its first direct-to-consumer oncology campaign with a spot for its metastatic breast cancer drug Verzenio. The drugmaker and ad firm Grey talked with over 300 women with the disease so they could achieve a responsible, authentic portrayal of their voices, and the ad shows these women as relentless, optimistic and strong.

Full Story:
FiercePharma
4/20/2018

Facebook's recent data privacy troubles probably won't have an impact on pharma, but marketers should still stay informed on the issue, industry experts say. Pharma companies only use data from Facebook for content or one-way ads targeting customers, rather than directly collect data though the social site, says Brad Einarsen of Klick Health.

Full Story:
FiercePharma
4/20/2018

Sensus Healthcare, a Boca Raton, Fla.-based company that makes low-energy photon X-ray systems for the treatment of nonmelanoma skin cancer and keloids, is looking to expand globally and has entered distribution deals in Cuba, Mexico, Germany, China and Costa Rica. The expansion will be led by Rick Golin, the company's executive vice president of oncology and international sales.

Full Story:
MassDevice (Boston)
More Summaries:
Sensus Healthcare
4/20/2018

A round of Series B financing brought in more than $10 million for Santa Cruz, Calif.-based Emboline, which makes the Emboliner Embolic Protection Catheter for protecting the cerebral system in transcatheter aortic valve replacement procedures. The proceeds will be used for a clinical trial of the device, submission for CE mark approval and initial commercial release.

Full Story:
FinSMEs
More Summaries:
Emboline, Emboline
4/20/2018

A deal was reached by Biotronik with Aziyo Biologics to co-distribute Aziyo's CanGaroo bio-envelopes in the US. The envelopes, which are branded as the Bio Envelope and became available this month, are intended for holding cardiovascular implantable devices to mitigate device migration and erosion risks and make device removal less complex during exchanges or revisions.

Full Story:
MassDevice (Boston)
4/20/2018

A three-year agreement was signed by Xtant Medical with Healthcare International Partners for the expansion of Xtant's products in Latin American markets. Among the deal's areas of focus are support for current distribution partners, recruitment of partners for new markets, execution of Xtant's global strategy and aid in country-specific registration of products.

Full Story:
Becker's Spine Review
4/20/2018

UgenTec and Serosep will partner to allow Serosep's EntericBio assay range to be included in UgenTec's FastFinder platform. Through the collaboration, existing and new EntericBio customers will be able to take advantage of artificial intelligence- and automation-supported standardized diagnostic interpretation enabled through the platform.

More Summaries:
UgenTec, Serosep
4/20/2018

Stephan Soyka was tapped to serve as managing director for B. Braun's Korean branch in Seoul, South Korea. Soyka previously served in various leadership positions at Abbott Laboratories, Bayer and Solvay Pharma.